1556 results for Leukemia

Refine Your Search

Robyn

Robyn

In October 2017, my wife Robyn Oshita passed away after a valiant two-and-a-half month battle against acute myeloid leukemia (AML). She was a loving w…

Ashley

Ashley

I grew up hearing stories about when my uncle Mark was diagnosed with leukemia. The heartache, the stress on the family, the fear and luckily for all…

Drew

Drew

One thought that never crossed my mind as a parent was the fear of a cancer diagnosis for my five year old son. A few months shy of his 6th Birthda…

New Series-Research Highlight: Acute Lymphoblastic Leukemia-New Targets, Pathways and Therapies

LLS Community is launching a new series focused on highlighting research in blood cancer. The first in this series focuses on Acute Lymphoblastic Leuk…

Eastern PA - Delaware Region Board of Trustees

The Eastern Pennsylvania - Delaware Region Board of Trustees is a group of distinguished individuals who serve as ambassadors for The Leukemia and Lym…

Jennifer

Jennifer

In 1985, 10-year-old Jennifer took to the stage to accept The Leukemia & Lymphoma Society’s (LLS) “Employee of the Year” award for her mother, Teresa …

Zac

Zac

In 2019, at 32, several symptoms culminated and, in hindsight, were red flags to the disease progression of acute myeloid leukemia (AML). I was less t…

Education Resources

Charlene

Charlene

Cancer. That is a word that is scary. So many of us have friends, family and co-workers that are impacted by some type of cancer, but you never think …

Suggested Reading - CAR T-Cell Therapy: What to Expect

Suggested Reading - CAR T-Cell Therapy: What to Expect

CAR T-Cell Therapy: What to Expect Before, During and After by Susan K. StewartPublished by Blood & Marrow Transplant Information Network, 2020, 26 Pa…

Halimeh

Halimeh

On June 3, 2014, I went to my local hospital for blood work after noticing unexplained bruising and experiencing a nose bleed. That day changed my lif…

A phase 1 expansion study of ICT01, an anti-BTN3A monoclonal antibody, in combination with azacitidine and venetoclax in patients with AML

In June 2022, LLS made an equity investment in ImCheck Therapeutics to "Support Clinical Development of the ICT01 Program for Blood Cancer Indications…

Gisenia

Gisenia

In October 2015, Gisenia Reyes heard the words "You have cancer." Diagnosed with acute myeloid leukemia (AML), an aggressive type of blood cancer. She…

Carson

Carson

In October 2016, after a few months of asymptomatic fevers, joint pain, and extreme irritability, Carson was admitted to the University of Virginia Ch…

John

John

I've been a cancer survivor since my bone marrow transplant at Seattle Cancer Care Alliance in 2004. I have minimal side effects and continue doing w…

Bonnie

Bonnie

My dad, Larry Vogl, was diagnosed with leukemia out of the blue in November 2014. In the picture, he is with my three boys and my nephew (his four gra…

Visionaries of the Year: A Campaign Powered by People Imagining a World Without Blood Cancer and Taking Action

Visionaries of the Year: A Campaign Powered by People Imagining a World Without Blood Cancer and Taking Action

The Leukemia & Lymphoma Society's philanthropic competition dedicates 10 weeks to end blood cancer

LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors

LLS Statement on COVID-19 Omicron Variant for Blood Cancer Patients and Survivors

Given the rapid rise in COVID-19 infections caused by the Omicron variant, The Leukemia & Lymphoma Society has developed this page to provide blood ca…

Dominic

Dominic

Our son Dominic was diagnosed with MLL-rearranged acute myeloid leukemia (AML) on July 14, 2020. The mixed-lineage leukemia (MLL) gene rearrangement i…

Childhood and Young Adult Resources

On this Page:Resources for Children, Young Adults and ParentsResources for Healthcare ProfessionalsResources for Children, Young Adults and ParentsOne…

Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns

Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns

The new report published by The Leukemia & Lymphoma Society and Manatt Health offers concrete policy solutions.

News Release

A phase 2 expansion study of ICT01, an anti-BTN3A monoclonal antibody, in combination with azacitidine and venetoclax in patients with AML

In June 2022, LLS made an equity investment in ImCheck Therapeutics to "Support Clinical Development of the ICT01 Program for Blood Cancer Indications…

Ellie

Ellie

Because she did not have symptoms, Ellie's diagnosis of Acute Lymphocytic Leukemia (ALL) at age four was incredibly shocking. Just one month after dia…

YAconnect: Young Adults Living with Leukemia, Lymphoma and Myeloma

GoFundMe

GoFundMe helps people help each other by using a community-powered fundraising platform to raise money for anything you or your loved one may need dur…

Suggested Reading - Hundred Percent Chance

Suggested Reading - Hundred Percent Chance

Hundred Percent Chance: A Memoir by Robert K. Brown3/3 Press 2019, 273 Pages, Paperback or KindleISBN: 9781733159005Hundred Percent Chance: A Memoir i…

Diane

Diane

Mary was diagnosed with acute myeloid leukemia (AML) in May 2016. After a few rounds of chemotherapy that were ineffective in fighting the AML, she wa…